Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
TechnipFMC
FTI
$27.4B
| $24.3M | 0.02% |
1,779,677
+249
| +0% | +$3.37K |
|
302
WSFS Financial
WSFS
$4.23B
| $24.3M | 0.02% |
645,810
+258,688
| +67% | +$11.9M |
|
303
Lockheed Martin
LMT
$134B
| $24.1M | 0.02% |
51,081
+484
| +1% | +$227K |
|
304
James River Group Holdings
JRVR
$219M
| $23.7M | 0.02% |
1,147,637
+14,786
| +1% | +$326K |
|
305
United Parcel Service
UPS
$88.3B
| $23.6M | 0.02% |
121,820
+7,557
| +7% | +$1.39M |
|
|
HZNP
306
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $23.3M | 0.02% |
213,669
-310,009
| -59% | -$34.3M |
|
307
Zurn Elkay Water Solutions
ZWS
$8.81B
| $23.3M | 0.02% |
1,090,404
-1,029,792
| -49% | -$22.7M |
|
308
Coupang
CPNG
$28.7B
| $23.2M | 0.02% |
1,451,517
-6,312,878
| -81% | -$97.8M |
|
309
Texas Instruments
TXN
$255B
| $23.2M | 0.02% |
124,840
-877
| -0.7% | -$154K |
|
310
SLM Corp
SLM
$5.19B
| $23.1M | 0.02% |
1,863,298
-2,340,640
| -56% | -$34.6M |
|
311
Regeneron Pharmaceuticals
REGN
$79.9B
| $23.1M | 0.02% |
+28,090
| New | +$21.2M |
|
312
Neurocrine Biosciences
NBIX
$16.3B
| $22.9M | 0.02% |
226,380
+6,993
| +3% | +$728K |
|
313
Dollar General
DG
$28.1B
| $22.6M | 0.02% |
107,315
+8,418
| +9% | +$1.89M |
|
314
ExxonMobil
XOM
$631B
| $22.3M | 0.02% |
203,443
-112,273
| -36% | -$12.4M |
|
315
Pinduoduo
PDD
$128B
| $22M | 0.02% |
289,480
-279,127
| -49% | -$25.2M |
|
316
Agnico Eagle Mines
AEM
$84.7B
| $21.7M | 0.02% |
425,396
+1,512
| +0.4% | +$77.6K |
|
317
Boot Barn
BOOT
$5.02B
| $21.6M | 0.02% |
282,266
+21,622
| +8% | +$1.66M |
|
|
EXE
318
Expand Energy Corp
EXE
$21.3B
| $21.5M | 0.02% |
283,252
-527
| -0.2% | -$43.4K |
|
319
FIVE9
FIVN
$2.23B
| $21.5M | 0.02% |
297,586
-6,495
| -2% | -$465K |
|
320
ACV Auctions
ACVA
$1.31B
| $21.5M | 0.02% |
1,662,393
+192,817
| +13% | +$2.11M |
|
321
Pembina Pipeline
PBA
$27.8B
| $21.4M | 0.02% |
662,142
-1,402
| -0.2% | -$47.3K |
|
|
UMH
322
UMH Properties
UMH
$1.3B
| $21.2M | 0.02% |
1,430,323
-762,923
| -35% | -$12.5M |
|
323
Integra LifeSciences
IART
$1.37B
| $20.7M | 0.02% |
360,086
+771
| +0.2% | +$43.4K |
|
|
VRNA
324
DELISTED
Verona Pharma
VRNA
| $20.7M | 0.02% |
1,028,998
-1,629
| -0.2% | -$35.2K |
|
|
GTM
325
ZoomInfo Technologies
GTM
$1.17B
| $20.4M | 0.02% |
826,046
-6,704,753
| -89% | -$172M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.